Over 161.1 million PCR tests have been conducted in the country so far
coronavirus2 days ago
Europe's medicines regulator on Friday recommended approving the use of Moderna's Covid-19 vaccine in 12- to 17-year olds, paving the way for it to become the second shot okayed for adolescent use in the bloc.
The use of the vaccine, branded Spikevax, will be the same in adolescents as in people above 18 years, the European Medicines Agency (EMA) said, adding the vaccine produced a comparable antibody response to that seen in 18- to 25-year olds.
Vaccinating children has been considered important for reaching herd immunity against the novel coronavirus and in the light of the highly contagious Delta variant. Moderna in May said its vaccine was found to be safe and effective in teens.
EMA's safety committee said while common side effects in teenagers after vaccination were similar to those seen in older population, due to a smaller study size, the trial could not detect new uncommon side effects or estimate the risk of known ones such as myocarditis and pericarditis
Over 161.1 million PCR tests have been conducted in the country so far
coronavirus2 days ago
Health official assured that the transmission rate of monkeypox among humans is relatively low
coronavirus3 days ago
Over 160.9 million PCR tests have been conducted in the country so far
coronavirus3 days ago
'It does not require sample preparation or a skilled medical specialist'
coronavirus3 days ago
The total doses administered now stand at 24.8 million
coronavirus4 days ago
Total active cases stand at 13,904
coronavirus4 days ago
The country never went into lockdown or closed businesses, largely relying instead on individual responsibility
coronavirus4 days ago
In 2021, it was labelled a Covid-19 success and reported 15,000 cases a day
coronavirus4 days ago